Compare NUCL & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUCL | KRMD |
|---|---|---|
| Founded | 2023 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.4M | 146.4M |
| IPO Year | 2026 | 2019 |
| Metric | NUCL | KRMD |
|---|---|---|
| Price | $4.53 | $3.00 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.25 |
| AVG Volume (30 Days) | 158.9K | ★ 165.1K |
| Earning Date | 10-13-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | N/A | $16.78 |
| Revenue Next Year | N/A | $17.22 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $4.55 | $2.86 |
| 52 Week High | $14.22 | $6.61 |
| Indicator | NUCL | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 23.81 | 44.58 |
| Support Level | N/A | $2.86 |
| Resistance Level | $6.45 | $3.41 |
| Average True Range (ATR) | 0.26 | 0.14 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 5.93 | 34.52 |
Eagle Nuclear Energy Corp is a next-generation nuclear energy company that seeks to combine domestic uranium exploration and development with proprietary small modular reactor (SMR) technology. It holds rights to the mineable, measured, and indicated uranium deposit in the United States, known as the Aurora Uranium Project, located in southeastern Oregon. The Aurora Uranium Project includes the Aurora deposit, with an estimated resource of 32.75 million pounds (Indicated) and 4.98 million pounds (Inferred) of near-surface uranium, and the adjacent Cordex zone.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.